SCA
ENZ

Secor Capital Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Secor Capital Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-31,649
Closed -$164K – 597
2018
Q2 		$164K Buy
31,649
+13,239
+72% +$80.7K 0.01% 463
2018
Q1 		$101K Buy
+18,410
New +$130K 0.01% 491
2017
Q4 		– Sell
-30,844
Closed -$323K – 606
2017
Q3 		$323K Buy
+30,844
New +$342K 0.03% 379

Other funds holding ENZ

EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Secor Capital Advisors's ENZ Position: Q3 2018 in Review

Secor Capital Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q3 2018, closing a stake of 31,649 shares — an estimated $164K sold.

Secor Capital Advisors first reported a position in ENZ in Q3 2017 and held it in 3 quarters. The position peaked at $323K in Q3 2017. 101 funds tracked by Wall St. Rank hold ENZ as of Q3 2018.

  • Secor Capital Advisors reported no remaining Enzo Biochem, Inc. position as of Q3 2018 after selling out during the quarter.
  • Secor Capital Advisors sold 31,649 Enzo Biochem, Inc. shares in Q3 2018, an estimated $164K.
  • Secor Capital Advisors first reported a position in Enzo Biochem, Inc. in Q3 2017 and held it in 3 quarters.
  • Secor Capital Advisors's Enzo Biochem, Inc. position peaked at $323K in Q3 2017.
  • 101 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2018.

Based on Secor Capital Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.